Peyman Kelk

Prof. Peyman Kelk

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2010 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
CDCharles Dinarello
Charles Dinarello
WAWilliam Arend
William Arend
JSJohn Sims
John Sims
DSDirk Smith
Dirk Smith
HBHal Blumberg
Hal Blumberg
CGChiristopher Gabel
Chiristopher Gabel

12 December 2014 in Virulence
Verified
Journal Article
Open access
CÅCarola Höglund Åberg
Carola Höglund Åberg
PKPeyman Kelk
Peyman Kelk
Anders JohanssonAnders Johansson
Anders Johansson
Periodontitis is an infection-induced inflammatory disease that causes loss of the tooth supporting tissues. Much focus has been put on comparison of the microbial biofilm in the healthy periodontium with the diseased one. The information arising from such studies is limited due to difficulties to compare the microbial composition in these two completely different ecological niches. A few longitudinal studies have contributed with information that makes it possible to predict which individuals who might have an increased risk of developing aggressive forms of periodontitis, and the predictors are either microbial or/and host-derived factors. The most conspicuous condition that is associated with disease risk is the presence of Aggregatibacter actinomycetemcomitans at the individual level. This Gram-negative bacterium has a great genetic variation with a number of virulence factors. In this review we focus in particular on the leukotoxin that, based on resent knowledge, might be one of the most important v...

3 October 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MKMallappa K. Kolar
Mallappa K. Kolar
VIVinay N. Itte
Vinay N. Itte
PKPaul Kingham
Paul Kingham
LNLev N. Novikov
Lev N. Novikov
MWMikael Wiberg
Mikael Wiberg
PKPeyman Kelk
Peyman Kelk
The current gold standard treatment for peripheral nerve injury is nerve grafting but this has disadvantages such as donor site morbidity. New techniques focus on replacing these grafts with nerve conduits enhanced with growth factors and/or various cell types such as mesenchymal stem cells (MSCs). Dental-MSCs (D-MSCs) including stem cells obtained from apical papilla (SCAP), dental pulp stem cells (DPSC), and periodontal ligament stem cells (PDLSC) are potential sources of MSCs for nerve repair. Here we present the characterization of various D-MSCs from the same human donors for peripheral nerve regeneration. SCAP, DPSC and PDLSC expressed BDNF, GDNF, NGF, NTF3, ANGPT1 and VEGFA growth factor transcripts. Conditioned media from D-MSCs enhanced neurite outgrowth in an in vitro assay. Application of neutralizing antibodies showed that brain derived neurotrophic factor plays an important mechanistic role by which the D-MSCs stimulate neurite outgrowth. SCAP, DPSC and PDLSC were used to treat a 10 mm nerve gap defect in a rat sciatic nerve injury model. All the stem cell types significantly enhanced axon regeneration after two weeks and showed neuroprotective effects on the dorsal root ganglia neurons. Overall the results suggested SCAP to be the optimal dental stem cell type for peripheral nerve repair.

1 August 2003 in Infection and Immunity
Verified
Journal Article
Open access
PDF file
PKPeyman Kelk
Peyman Kelk
Anders JohanssonAnders Johansson
Anders Johansson
RCR. Claesson
R. Claesson
LHL. HänStröm
L. HänStröm
SKS. Kalfas
S. Kalfas
Actinobacillus actinomycetemcomitans , an oral bacterium implicated in the etiology of periodontal diseases, produces a leukotoxin that selectively lyses primate neutrophils and monocytes, the major populations of defense cells in the periodontium. Though lysis requires expression of the receptor lymphocyte function-associated molecule 1 (LFA-1) on the cell surface, not all LFA-1-expressing leukocyte populations are equally susceptible to the toxin. In this study, the susceptibility of human leukocytes to leukotoxin-induced lysis is compared to their expression of LFA-1 and the activity of caspase 1. Cytolysis was determined by the activity of lactate dehydrogenase released from peripheral human leukocytes after 1-h exposure to leukotoxin. Monocytes were lysed at leukotoxin concentrations of ≥5 ng/ml, while the corresponding values for neutrophils and lymphocytes were approximately 10 times greater. Similar LFA-1 expression was found in all susceptible cell populations irrespective of their degree of sensitivity to the toxin. Exposure of monocytes to leukotoxin increased their caspase 1 activity about fivefold within 10 to 20 min. Presence of the caspase 1 inhibitor Ac-YVAD-CMK significantly blocked the leukotoxin-induced lysis of monocytes only. At sublytic concentrations, leukotoxin induced no apoptotic activity in monocytes, as revealed by the lack of caspase 3 activation and DNA fragmentation. Monocytes are the most lysis-sensitive leukocytes for A. actinomycetemcomitans leukotoxin. Their lysis by this toxin depends on caspase 1 activation and proceeds through a process that differs from classical apoptosis.

10 March 2011 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
PKPeyman Kelk
Peyman Kelk
HAH Abd
H Abd
RCR Claesson
R Claesson
GSG Sandström
G Sandström
Anders SjöstedtAnders Sjöstedt
Anders Sjöstedt
AJA Johansson
A Johansson
Aggregatibacter (Actinobacillus) actinomycetemcomitans is a facultative anaerobic gram-negative bacterium associated with severe forms of periodontitis. A leukotoxin, which belongs to the repeats-in-toxin family, is believed to be one of its virulence factors and to have an important role in the bacterium's pathogenicity. This toxin selectively kills human leukocytes by inducing apoptosis and lysis. Here, we report that leukotoxin-induced cell death of macrophages proceeded through a process that differs from the classical characteristics of apoptosis and necrosis. A. actinomycetemcomitans leukotoxin-induced several cellular and molecular mechanisms in human macrophages that led to a specific and excessive pro-inflammatory response with particular secretion of both interleukin (IL)-1β and IL-18. In addition, this pro-inflammatory cell death was inhibited by oxidized ATP, which indicates involvement of the purinergic receptor P2X7 in this process. This novel virulence mechanism of the leukotoxin may have an important role in the pathogenic potential of this bacterium and can be a target for future therapeutic agents.

25 December 2012 in Cell Research
Verified
Journal Article
Closed access
RYRuili Yang
Ruili Yang
YLYi Liu
Yi Liu
PKPeyman Kelk
Peyman Kelk
CQCunye Qu
Cunye Qu
KAKentaro Akiyama
Kentaro Akiyama
SSSongtao Shi
Songtao Shi